Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central nervous system sympathetic activity refers to the regulation and generation of sympathetic nerve signals originating from central neural circuits (hypothalamus, medulla, spinal cord) that control the "fight or flight" response and ongoing homeostatic functions. Through descending projections and autonomic ganglia, these signals regulate vital processes including heart rate, vascular tone, and metabolism. Dysregulation of central sympathetic tone is implicated in hypertension, heart failure, stress disorders, and several other diseases. It is not a molecular target but a network activity subject to pharmacological modulation by agents acting at specific receptors (primarily alpha-2 adrenergic and imidazoline receptors) within CNS regions controlling autonomic function[8][6][1][9].
Central alpha-2 adrenergic receptor activation (reduces sympathetic outflow)[8][6]; Imidazoline receptor activation (reduces sympathetic tone from CNS)[8]; Peripheral beta-adrenergic blockade (blocks effects of SNS, does not directly reduce central activity)[6]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sympathetic nervous system activity (central control) (SNS activity (CNS)).